News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • IMF says Middle East war will raise immediate demand for $20–50 billion in balance‑of‑payments support and signals a growth outlook downgrade.
  • Software stocks fell as Palantir, Microsoft and peers dropped on investor concern about Anthropic's new Mythos model and agent tools.
  • Analysts issued tactical buy calls on Amazon, Rolls‑Royce, Alibaba, GM and Denison, citing AI, aerospace, EVs and uranium catalysts.
  • Canada's TSX slipped as ceasefire fragility and crude swings dented sentiment, while gold rallied on safe‑haven demand.
  • Ares will take Whitestone REIT private for about $1.7 billion at $19 per share, board unanimously approved.
  • Fox shares rose after DOJ opened an inquiry into NFL distribution practices, boosting broadcast rights competition hopes.

Latest Articles

Alpha Modus Awarded Foundational Patent Covering Real-Time, AI-Driven Personalized Marketing in Retail Stores

Alpha Modus Awarded Foundational Patent Covering Real-Time, AI-Driven Personalized Marketing in Retail Stores

Alpha Modus Holdings, Inc. announced the issuance of U.S. Patent No. 12,591,901 covering innovative AI-driven methods for real-time, personalized marketing in physical retail stores. This foundational patent secures the company's leadership in leveraging in-store behavioral data to deliver dynamic, shopper-specific promotions and pricing via variou…

Nexxen Announces March 2026 Share Repurchase Program Summary

Nexxen Announces March 2026 Share Repurchase Program Summary

Nexxen International Ltd., an advertising technology company traded on NASDAQ, completed its $20 million share repurchase program by buying back over 224,000 shares in March 2026. The company now announces a new, larger $40 million repurchase program, signaling confidence in its business and commitment to shareholder value.

Willis Lease Finance Corporation Closes Two Additional JOLCO Deals, Bringing Total JOLCO Financing to Nearly $150 Million

Willis Lease Finance Corporation Closes Two Additional JOLCO Deals, Bringing Total JOLCO Financing to Nearly $150 Million

Willis Lease Finance Corporation announced the closing of two additional Japanese Operating Lease with Call Option (JOLCO) transactions, totaling approximately $50 million in financing for LEAP-1A and LEAP-1B aircraft engines. These deals increase the company's total JOLCO financing to nearly $150 million and provide diversified term financing to s…

Live Ventures Company Central Steel Fabricators Contributes to Hyperscale AI Data Center Infrastructure Expansion

Live Ventures Company Central Steel Fabricators Contributes to Hyperscale AI Data Center Infrastructure Expansion

Live Ventures Incorporated's subsidiary, Central Steel Fabricators, announced its role in supplying structural support products for a major hyperscale data center project driven by AI adoption. The company emphasizes its capability to deliver high-quality steel systems essential for data center connectivity and infrastructure, highlighting ongoing …

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

electroCore, Inc. announced the publication of clinical findings demonstrating that adjunctive non-invasive vagus nerve stimulation (nVNS) significantly reduces symptoms in patients with chronic mild traumatic brain injury (mTBI) and comorbid post-traumatic stress disorder (PTSD). The study showed improvements across cognitive, affective, and somat…

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

Cogent Biosciences has completed the submission of a New Drug Application (NDA) to the FDA for bezuclastinib in treatment-resistant Gastrointestinal Stromal Tumors (GIST) patients, based on strong Phase 3 PEAK trial results. The application was submitted under the FDA's expedited Real-Time Oncology Review program. The PEAK trial demonstrated signif…

Greenlane Holdings, Inc. Announces 1-for-8 Reverse Stock Split

Greenlane Holdings, Inc. Announces 1-for-8 Reverse Stock Split

Greenlane Holdings, Inc., a Nasdaq-listed digital asset treasury company focused on Berachain blockchain assets, announced a 1-for-8 reverse stock split effective April 6, 2026. The split aims to improve the perception of its stock, broaden investor appeal, and maintain compliance with Nasdaq listing rules. The total shares outstanding will reduce …

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Elite Surgical Technologies to deploy the Nanox.ARC digital tomosynthesis imaging system across five U.S. states, targeting orthopedic practices and post-surgical care settings. The partnership aims to enhance adoption of cost-effective, low-radiation 3D imaging to monitor b…

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics will present new data on its RedTail virotherapy platform at the AACR Annual Meeting 2026, highlighting its novel approach to simultaneously activate T-cells and induce high expression of T-cell engagers specifically in the tumor microenvironment. The company’s lead candidate, CLD-401, targets multiple solid tumors and is pro…

Tri Pointe Homes Named to 2026 Fortune 100 Best Companies to Work For® List, Honoring its Dedication to People-First Culture, Innovation, and Career Growth

Tri Pointe Homes Named to 2026 Fortune 100 Best Companies to Work For® List, Honoring its Dedication to People-First Culture, Innovation, and Career Growth

Tri Pointe Homes (NYSE: TPH), a major U.S. homebuilder, has been named to the 2026 Fortune 100 Best Companies to Work For list for the third time, recognizing its commitment to a people-first culture, innovation, and career growth. The company continues to enhance professional development, implement AI and technology initiatives, expand recruiting …

Apollo Funds Acquire Gatehouse Living Group from Gatehouse Bank

Apollo Funds Acquire Gatehouse Living Group from Gatehouse Bank

Apollo Global Management announced that funds it manages have acquired Gatehouse Living Group (GLG), a leading UK residential investment and property management platform, from Gatehouse Bank. The acquisition enhances Apollo's presence in the UK housing market, complementing its existing investments in UK homebuilding and mortgage lending. GLG will …

NOVAGOLD Files First Quarter 2026 Report Highlighting Growing Momentum on Key Donlin Gold Workstreams

NOVAGOLD Files First Quarter 2026 Report Highlighting Growing Momentum on Key Donlin Gold Workstreams

NOVAGOLD Resources Inc. reported significant progress in the first quarter of 2026 on its Donlin Gold project, highlighted by the launch of a Bankable Feasibility Study (BFS) led by Fluor Corporation and awarding strategic engineering contracts to advance critical infrastructure. The company completed an upsized private placement raising approximat…

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Ardelyx, a US-based biopharmaceutical company, announced the appointment of Dr. Rajani Dinavahi as its new Chief Medical Officer. With over 20 years of experience in biotechnology and healthcare, Dr. Dinavahi will lead clinical development and medical affairs to strengthen Ardelyx's pipeline and advance its innovative medicines to market. This lead…